NCT04749082 is a clinical trial in Spondylodiscitis, sponsored by Assiut University.

Who is sponsoring NCT04749082?

NCT04749082 is sponsored by Assiut University.

What condition does NCT04749082 study?

NCT04749082 studies Spondylodiscitis.

Is NCT04749082 still recruiting?

NCT04749082 is currently status unknown. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT04749082

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Follow up Patients With Thoracolumbar Spondylodiscitis Surgically Treated by Posterior Approach

Status unknown Last updated 10 February 2021

What this trial tests

trial in Spondylodiscitis in 40 participants. Status unknown.

Timeline

31 January 2021

Primary endpoint
30 June 2021

1 July 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	31 January 2021
Primary completion	30 June 2021
Estimated completion	1 July 2021

Conditions studied

Spondylodiscitis — all drugs for Spondylodiscitis →

Sponsor

Assiut University

Who can join

Adults 20 to 85, any sex, with Spondylodiscitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the long term outcomes of patients with thoracolumbar spondylodiscitis treated surgically by posterior approach. Outcomes include bony fusion, neurological improvement, pain improvement, implant related complication, recurrence of infection and or reoperation rate

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spondylodiscitis

Currently open trials in the same condition.

NCT06666023 — Paper-based Electrochemical Point-of-care Device in Diagnostic of Orthopedic Infections · recruiting
NCT05610098 — Gene Expression Profiles in Spinal Tuberculosis. · recruiting
NCT07164235 — Spondylodiscitis: a Retrospective Observational Study. · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04749082 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing